Year founded
-
Country of origin
United States
HQ country
United States
Total deal value
Average deal value
Company industry
- Healthcare & Pharmaceuticals
M&A expertise
- -
Industry expertise
- Healthcare & Pharmaceuticals
BioClin Therapeutics, Inc. is a biotechnology company that develops protein therapeutics for genetic disorders. The company’s lead candidate is B-701, a potential first-in-class human monoclonal antibody targeting FGFR3 (fibroblast growth factor receptor 3). The company was founded in 2010 and is based in San Ramon, California.